Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Real-world effectiveness of vonoprazan-based regimen versus rabeprazole-based dual therapy for Helicobacter pylori eradication in a high-resistance, multi-ethnic region: a multicenter study in Guizhou, China.
Journal: Frontiers in medicine
Published: February 01, 2026
Substance Use Disorders Are Associated With Increased Long-Term Risks of Gastroesophageal Reflux Disease Phenotypes: A Global Propensity-Matched Cohort Study.
Journal: Neurogastroenterology and motility
Published: January 27, 2026
Acid-Suppressive Therapy Choice and Risk of Treatment Escalation in Inflammatory Bowel Disease: A Real-World Comparative Retrospective Study to Inform Personalized Treatment.
Journal: Journal of personalized medicine
Published: January 22, 2026
Associations of Psychological Distress with Esophageal Functional Metrics in Patients with Refractory Reflux-Like Symptoms: A Retrospective Study.
Journal: The Tohoku journal of experimental medicine
Published: January 14, 2026
Novel non-antibiotic triple therapy for Helicobacter pylori-positive functional dyspepsia patients resistant to conventional antibiotic treatments: an exploratory pilot study.
Journal: Frontiers in medicine
Published: December 02, 2025
Fasting Duration, Not Timing of Last GLP-1 Dose, Predicts Aspiration Risk Indicators: A Prospective Point-of-Care Gastric Ultrasound Study.
Journal: Digestive diseases and sciences
Published: September 22, 2025
The Hidden Burden of Gastroparesis in Chronic Kidney Disease: Evidence from Inpatient and Outpatient Cohorts for Personalized Care.
Journal: Journal of personalized medicine
Published: August 11, 2025
Diagnostic Evaluation of an Increased Risk of Developing Small Intestinal Bacterial Overgrowth Associated with Glucagon-like Peptide-1 (GLP-1) Receptor Agonists and Dual GLP-1/GIP Receptor Agonists: A Global Retrospective Multicenter Cohort Analysis.
Journal: Diagnostics (Basel, Switzerland)
Published: July 18, 2025
Progressive Increase in Small Intestinal Bacterial Overgrowth Risk Following COVID-19 Infection: A Global Population-Based Study.
Journal: Diseases (Basel, Switzerland)
Published: July 16, 2025
Some Risks of Gastrointestinal Adverse Events Associated With Glucagon-Like PEPTIDE-1 Receptor Agonists Are Likely Explained by BMI.
Journal: Alimentary pharmacology & therapeutics
Published: April 20, 2025
How Are Pregnant Patients With Irritable Bowel Syndrome or Functional Dyspepsia Managed Pharmacologically? A Cross-Sectional Study Using a Global Database.
Journal: Neurogastroenterology and motility
Published: August 09, 2024
Last Updated: 09/26/2026